IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lion Point Capital, LP

Q3 2024 Holdings

Filed 2024-11-14 | 25 holdings | $44.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ishares TR(IWM)PutRUSSELL 2000 ETF464287655$18.2M82,50040.6%
Insmed Inc(INSM)COM PAR $.01457669307$3.8M52,2008.5%
Geron Corp(GERN)COM374163103$2.9M630,0006.4%
Ardelyx Inc(ARDX)COM039697107$2.5M370,0005.7%
Milestone Pharmaceuticals in(MIST)COM59935V107$2.5M1,654,1545.6%
Biohaven LTD(BHVN)COMG1110E107$1.8M35,4003.9%
Mirum Pharmaceuticals Inc(MIRM)PutCOM604749101$1.8M45,0003.9%
Kiniksa Pharmaceuticals LTD(KNSA)ORD SHS CL AG52694109$1.5M61,4003.4%
Bridgebio Pharma Inc(BBIO)COM10806X102$1.2M49,0002.8%
Marinus Pharmaceuticals Inc(MRNS*)COM NEW56854Q200$1.2M693,7782.7%
Fennec Pharmaceuticals Inc(FENC)COM31447P100$1.1M215,0002.4%
Mineralys Therapeutics Inc(MLYS)COM603170101$956.7K79,0002.1%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$889.4K46,2002.0%
Avadel Pharmaceuticals PLCCOM SHSG29687103$839.4K64,0001.9%
Bluebird BIO IncCOM09609G100$819.9K1,578,2561.8%
Regenxbio Inc(RGNX)COM75901B107$605.8K57,7501.3%
Jasper Therapeutics Inc(JSPR)COM NEW471871202$601.9K32,0001.3%
Disc Medicine Inc(IRON)COM254604101$378.4K7,7000.8%
Benitec Biopharma Inc(BNTC)COM NEW08205P209$358.4K39,0000.8%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$326.4K35,1000.7%
Seres Therapeutics Inc(MCRB1EUR)COM81750R102$322.4K340,7610.7%
Lumos Pharma IncCOM55028X109$153.2K39,5890.3%
Microsoft Corp(MSFT)COM594918104$43.0K1000.1%
Spruce Biosciences IncCOM85209E109$35.6K75,0000.1%
Alphabet Inc(GOOG)CAP STK CL C02079K107$16.7K1000.0%